Selective Culture Medium for Screening of Fosfomycin Resistance in


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
19 01 2022
Historique:
pubmed: 21 10 2021
medline: 16 3 2022
entrez: 20 10 2021
Statut: ppublish

Résumé

A selective medium for screening fosfomycin (FOS)-resistant

Identifiants

pubmed: 34669459
doi: 10.1128/JCM.02063-21
pmc: PMC8769723
doi:

Substances chimiques

Anti-Bacterial Agents 0
Fosfomycin 2N81MY12TE
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0206321

Références

Ann N Y Acad Sci. 1974 May 10;235(0):364-86
pubmed: 4605290
mBio. 2017 Aug 29;8(4):
pubmed: 28851843
J Antimicrob Chemother. 2016 Sep;71(9):2460-5
pubmed: 27261267
Acta Microbiol Immunol Hung. 2019 Mar 1;66(1):103-112
pubmed: 30403361
Antimicrob Agents Chemother. 2012 May;56(5):2767-9
pubmed: 22371901
Antimicrob Agents Chemother. 2010 Jul;54(7):3061-4
pubmed: 20404116
Microbiologyopen. 2020 Dec;9(12):e1135
pubmed: 33128341
Antimicrob Agents Chemother. 2019 Oct 22;63(11):
pubmed: 31481445
Microbiol Spectr. 2018 Jul;6(4):
pubmed: 30003866
Methods Enzymol. 2005;401:367-79
pubmed: 16399398
Emerg Infect Dis. 2017 Sep;23(9):1564-1567
pubmed: 28820368
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28674050
Eur J Clin Microbiol Infect Dis. 2019 May;38(5):945-949
pubmed: 30877486
J Antibiot (Tokyo). 1990 Mar;43(3):238-46
pubmed: 2182591
J Antibiot (Tokyo). 1986 Jul;39(7):1011-2
pubmed: 3759643
J Clin Microbiol. 2019 Jan 2;57(1):
pubmed: 30381418
Antimicrob Agents Chemother. 2020 Mar 24;64(4):
pubmed: 31932373
Annu Rev Biochem. 2009;78:65-94
pubmed: 19489722
Vet Microbiol. 2020 Apr;243:108619
pubmed: 32273005
Antimicrob Agents Chemother. 2020 Apr 21;64(5):
pubmed: 32122889
J Glob Antimicrob Resist. 2020 Jun;21:414-416
pubmed: 32061811
Science. 1969 Oct 3;166(3901):122-3
pubmed: 5809587
J Clin Microbiol. 2020 Aug 24;58(9):
pubmed: 32580951
J Clin Microbiol. 2014 Sep;52(9):3175-9
pubmed: 24951800
Infect Drug Resist. 2020 May 01;13:1273-1279
pubmed: 32431524
J Antimicrob Chemother. 2019 Dec 1;74(12):3630-3632
pubmed: 31511878
Lett Appl Microbiol. 2015 Mar;60(3):259-64
pubmed: 25441705

Auteurs

Patrice Nordmann (P)

Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourggrid.8534.a, Fribourg, Switzerland.
INSERM European Unit (IAME), University of Fribourggrid.8534.a, Fribourg, Switzerland.
Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourggrid.8534.a, Fribourg, Switzerland.
Institute for Microbiology, University of Lausanne and University Hospital Centre, Lausanne, Switzerland.

Mustafa Sadek (M)

Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourggrid.8534.a, Fribourg, Switzerland.
INSERM European Unit (IAME), University of Fribourggrid.8534.a, Fribourg, Switzerland.
Department of Food Hygiene and Control, Faculty of Veterinary Medicine, South Valley University, Qena, Egypt.

José Manuel Ortiz de la Rosa (JM)

Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourggrid.8534.a, Fribourg, Switzerland.
INSERM European Unit (IAME), University of Fribourggrid.8534.a, Fribourg, Switzerland.

Stefan Pfister (S)

Hôpital Fribourgeois-Hôpital Cantonal de Fribourg, Fribourg, Switzerland.

Claudine Fournier (C)

Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourggrid.8534.a, Fribourg, Switzerland.
Hôpital Fribourgeois-Hôpital Cantonal de Fribourg, Fribourg, Switzerland.

Laurent Poirel (L)

Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourggrid.8534.a, Fribourg, Switzerland.
INSERM European Unit (IAME), University of Fribourggrid.8534.a, Fribourg, Switzerland.
Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourggrid.8534.a, Fribourg, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH